Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;22:156-160

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lahera, V.
Right arrow Articles by Romero, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lahera, V.
Right arrow Articles by Romero, J. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*ACETYLCYSTEINE
*BENZOIC ACID, O-MERCAPTO-
Medline Plus Health Information
*Blood Pressure Medicines

Hypertension, Vol 22, 156-160, Copyright © 1993 by American Heart Association


ARTICLES

Sulfhydryl group donors potentiate the hypotensive effect of acetylcholine in rats

V Lahera, AA Khraibi and JC Romero
Department of Physiology and Biophysics, Mayo Medical School, Rochester, Minn. 55905.

Nitric oxide mediates the vasodilator and hypotensive responses of acetylcholine infusion. It has been reported that nitric oxide could be protected from free radical destruction by forming an S-nitrosothiol compound. Furthermore, sulfhydryl donors such as N-acetylcysteine or thiosalicylic acid enhance nitric oxide production from nitroglycerin. Consequently, the hypotensive effect of intravenous acetylcholine infusion might be potentiated during the simultaneous administration of sulfhydryl donors. The objective of the present study was to test in Okamoto spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats (1) whether the hypotensive effect of acetylcholine (10 micrograms/kg per minute) was affected by the simultaneous administration of N-acetylcysteine (10 micrograms/kg per minute) or thiosalicylic acid (10 micrograms/kg per minute), and (2) whether NG- nitro-L-arginine-methyl ester (100 micrograms/kg per minute) administration was able to reverse the changes induced by acetylcholine plus N-acetylcysteine or acetylcholine plus thiosalicylic acid. The administration of acetylcholine reduced (P < .05) mean arterial pressure in WKY rats (13 +/- 2%) and SHR (14 +/- 2%) without affecting urine flow rate, urinary sodium excretion, and glomerular filtration rate. In the presence of N-acetylcysteine, the acetylcholine-induced reduction in mean arterial pressure was potentiated (P < .05) in WKY rats (24 +/- 4%) and SHR (20 +/- 2%). These changes in mean arterial pressure were accompanied by significant reductions in urine flow rate and urinary sodium excretion in WKY rats, as well as in glomerular filtration rate in SHR.2


This article has been cited by other articles:


Home page
In VivoHome page
A. A. PAWAR, A. VIKRAM, D. N. TRIPATHI, S. PADMANABHAN, P. RAMARAO, and G. JENA
Modulation of Mitomycin C-induced Genotoxicity by Acetyl- and Thio- Analogues of Salicylic Acid
In Vivo, March 1, 2009; 23(2): 303 - 307.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
U. N. Das
Statins and the prevention of dementia
Can. Med. Assoc. J., October 1, 2001; 165(7): 908 - 909.
[Full Text] [PDF]


Home page
HypertensionHome page
A. F. Dominiczak and D. F. Bohr
Nitric Oxide and Its Putative Role in Hypertension
Hypertension, June 1, 1995; 25(6): 1202 - 1211.
[Full Text]


Home page
HypertensionHome page
F. J. Fenoy, P. Ferrer, L. Carbonell, and M. Garcia-Salom
Role of Nitric Oxide on Papillary Blood Flow and Pressure Natriuresis
Hypertension, March 1, 1995; 25(3): 408 - 414.
[Abstract] [Full Text]